248
Participants
Start Date
November 19, 2020
Primary Completion Date
March 24, 2023
Study Completion Date
October 6, 2023
AlloSure
AlloSure is an analytically validated targeted next-generation sequencing (NGS) assay that uses single-nucleotide polymorphisms (SNPs) to measure the fraction of dd-cfDNA in transplant patients without the need for genotyping either the donor or the recipient.8
Chinatown Kidney, New York
PRINE Health, Manhasset
Nephrology Associates PC, Queens, Queens
George Washington/Medical Faculty Associates Inc., Washington D.C.
Mendez Center for Clinical Research, Woodbridge
Lynchburg Nephrology Physicians, PLLC, Lynchburg
Physician Consultants of Georgia, Macon
NANI Research, Fort Wayne
NANI Research, Hinsdale
Washington University, St Louis
Sholer Chris MD, Oklahoma City
Utah Kidney Research Institute, South Ogden
Amicis Research Center, Granada Hills
Amicis Research Center, Mission Hills
California Institute of Renal Research (Balboa), San Diego
The Medical Research Group - Fresno, Fresno
Amicis Research Center, Fairfield
Starling Physicians, Hartford
Lead Sponsor
CareDx
INDUSTRY